St Paul Medical gets 510(k) for needleless intraveneous (IV) system:
This article was originally published in Clinica
St Paul Medical has received US FDA clearance to market its needleless IV system. Key-Lok uses blunt plastic cannulae in place of needles and latex-free female connector ports to reduce the chance of needlestick injuries and allergic responses. The American Journal of Infection Control estimates that there are 800,000 accidental needlestick injuries in the US every year. Some 16,000 healthcare workers are exposed to HIV and 130,000 to hepatitis B, incurring diagnosis and treatments costs of around $2,000 million.
You may also be interested in...
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.